The Role of Cdk5 in Alzheimer’s Disease

Molecular Neurobiology

Volumn 53, Issue 7, 2016, Pages 4328-4342

  Liu, Shu Lei ^a   Wang, Chong ^a   Jiang, Teng ^b   Tan, Lan ^a   Xing, Ang ^a   Yu, Jin Tai ^a,c  

^a QINGDAO UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer s disease; A ; Cdk5; Pathogenesis; Tau; Therapy

Indexed keywords

AMYLOID BETA PROTEIN; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 5 INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; CELL CYCLE; CELL DEATH; CELL SURVIVAL; HUMAN; MITOCHONDRION; MOLECULARLY TARGETED THERAPY; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; RNA INTERFERENCE; SYNAPSE; ANIMAL; BIOLOGICAL MODEL; ENZYMOLOGY; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; CYCLIN-DEPENDENT KINASE 5; HUMANS; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; NEURONAL PLASTICITY;

EID: 84938528109     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9369-x     Document Type: Review

References (135)

1. Jiang T, Chang RC et al (2015) Advances in Alzheimer’s disease: from bench to bedside. Biomed Res Int 2015:202676
2. Blennow K, de Leon MJ et al (2006) Alzheimer’s disease. Lancet 368(9533):387–403
3. Papon MA, Whittington RA et al (2011) Alzheimer’s disease and anesthesia. Front Neurosci 4:272
4. Wimo A, Prince M (2010) World Alzheimer Report 2010: the global economic impact of dementia (London: Alzheimer’s Disease International). Alzheimers Dis Int: 1–56. doi:10.3389/fnins.2010.00272
5. Asada A, Saito T et al (2012) Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner. J Cell Sci 125(Pt 14):3421–3429
6. Lee J, Yun N et al (2014) Acetylation of cyclin-dependent kinase 5 is mediated by GCN5. Biochem Biophys Res Commun 447(1):121–127
7. Kobayashi H, Saito T et al (2014) Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5. J Biol Chem 289(28):19627–19636
8. Qu J, Nakamura T et al (2012) S-nitrosylation of Cdk5: potential implications in amyloid-beta-related neurotoxicity in Alzheimer disease. Prion 6(4):364–370
9. Sun KH, Chang KH et al (2011) Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. J Neurochem 118(5):902–914
10. Takahashi M, Ishida M et al (2014) Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA. Biochem Biophys Res Commun 447(4):678–682
11. Lew J (2013) CDK5: a new lead to survival. Cell Cycle 12(13):1981–1982
12. Shah K, Lahiri DK (2014) Cdk5 activity in the brain—multiple paths of regulation. J Cell Sci 127(Pt 11):2391–2400
13. Hisanaga S, Endo R (2010) Regulation and role of cyclin-dependent kinase activity in neuronal survival and death. J Neurochem 115(6):1309–1321
14. Patrick GN, Zukerberg L et al (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402(6762):615–622
15. Quan H, Wu X et al (2014) Overexpression of CDK5 in neural stem cells facilitates maturation of embryonic neurocytes derived from rats in vitro. Cell Biochem Biophys 69(3):445–453
16. Duhr F, Deleris P et al (2014) Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth. Nat Chem Biol 10(7):590–597
17. Petrik D, Yun S et al (2013) Early postnatal in vivo gliogenesis from nestin-lineage progenitors requires cdk5. PLoS One 8(8):e72819
18. He X, Ishizeki M et al (2014) Cdk5/p35 is required for motor coordination and cerebellar plasticity. J Neurochem 131(1):53–64
19. Kumazawa A, Mita N et al (2013) Cyclin-dependent kinase 5 is required for normal cerebellar development. Mol Cell Neurosci 52:97–105
20. Buchner A, Krumova P et al (2015) Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity. Neuromol Med 17(1):12–23
21. Ye T, Ip JP et al (2014) Cdk5-mediated phosphorylation of RapGEF2 controls neuronal migration in the developing cerebral cortex. Nat Commun 5:4826
22. Nishimura YV, Sekine K et al (2010) Dissecting the factors involved in the locomotion mode of neuronal migration in the developing cerebral cortex. J Biol Chem 285(8):5878–5887
23. Tanabe K, Yamazaki H et al (2014) Phosphorylation of drebrin by cyclin-dependent kinase 5 and its role in neuronal migration. PLoS One 9(3):e92291
24. Worth DC, Daly CN et al (2013) Drebrin contains a cryptic F-actin-bundling activity regulated by Cdk5 phosphorylation. J Cell Biol 202(5):793–806
25. Contreras-Vallejos E, Utreras E et al (2014) Searching for novel Cdk5 substrates in brain by comparative phosphoproteomics of wild type and Cdk5-/- mice. PLoS One 9(3):e90363
26. Utreras E, Henriquez D et al (2013) Cdk5 regulates Rap1 activity. Neurochem Int 62(6):848–853
27. Takahashi S, Ohshima T et al (2010) Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration. Am J Pathol 176(1):320–329
28. Wong AS, Lee RH et al (2011) Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson’s disease. Nat Cell Biol 13(5):568–579
29. Yang Y, Wang H et al (2013) Cyclin dependent kinase 5 is required for the normal development of oligodendrocytes and myelin formation. Dev Biol 378(2):94–106
30. Mita N, He X et al (2014) Cyclin-dependent kinase 5 regulates dendritic spine formation and maintenance of cortical neuron in the mouse brain. Cereb Cortex. doi:10.1093/cercor/bhu264
31. Nishimura YV, Shikanai M et al (2014) Cdk5 and its substrates, Dcx and p27kip1, regulate cytoplasmic dilation formation and nuclear elongation in migrating neurons. Development 141(18):3540–3550
32. Antoniou X, Gassmann M et al (2011) Cdk5 interacts with Hif-1alpha in neurons: a new hypoxic signalling mechanism? Brain Res 1381:1–10
33. Jeong J, Park YU et al (2013) Cdk5 phosphorylates dopamine D2 receptor and attenuates downstream signaling. PLoS One 8(12):e84482
34. Lee MS, Kwon YT et al (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405(6784):360–364
35. Tseng HC, Zhou Y et al (2002) A survey of Cdk5 activator p35 and p25 levels in Alzheimer’s disease brains. FEBS Lett 523(1-3):58–62
36. Taniguchi S, Fujita Y et al (2001) Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett 489(1):46–50
37. Zhou J, Li H et al (2015) The roles of Cdk5-mediated subcellular localization of FOXO1 in neuronal death. J Neurosci 35(6):2624–2635
38. Chang KH, Multani PS et al (2011) Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death. Mol Biol Cell 22(9):1452–1462
39. Wen Z, Shu Y et al (2014) CDK5-mediated phosphorylation and autophagy of RKIP regulate neuronal death in Parkinson’s disease. Neurobiol Aging 35(12):2870–2880
40. Guan JS, Su SC et al (2011) Cdk5 is required for memory function and hippocampal plasticity via the cAMP signaling pathway. PLoS One 6(9):e25735
41. Huang E, Qu D et al (2010) The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death. Nat Cell Biol 12(6):563–571
42. Zhong P, Liu X et al (2014) Cyclin-dependent kinase 5 in the ventral tegmental area regulates depression-related behaviors. J Neurosci 34(18):6352–6366
43. Su SC, Rudenko A et al (2013) Forebrain-specific deletion of Cdk5 in pyramidal neurons results in mania-like behavior and cognitive impairment. Neurobiol Learn Mem 105:54–62
44. Crews L, Patrick C et al (2011) Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer’s disease. Cell Death Dis 2:e120
45. Barucker C, Sommer A et al (2015) Alzheimer amyloid peptide Abeta42 regulates gene expression of transcription and growth factors. J Alzheimers Dis 44(2):613–624
46. Mawuenyega KG, Sigurdson W et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 330(6012):1774
47. Bergmans BA, De Strooper B (2010) Gamma-secretases: from cell biology to therapeutic strategies. Lancet Neurol 9(2):215–226
48. Esler WP, Wolfe MS (2001) A portrait of Alzheimer secretases—new features and familiar faces. Science 293(5534):1449–1454
49. Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks. Nat Neurosci 13(7):812–818
50. Bertram L, Lill CM et al (2010) The genetics of Alzheimer disease: back to the future. Neuron 68(2):270–281
51. Querfurth HW, LaFerla FM (2010) Alzheimer’s disease. N Engl J Med 362(4):329–344
52. Zempel H, Thies E et al (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci 30(36):11938–11950
53. Liu F, Su Y et al (2003) Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5. FEBS Lett 547(1-3):193–196
54. Zheng YL, Kesavapany S et al (2005) A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J 24(1):209–220
55. Cruz JC, Tseng HC et al (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40(3):471–483
56. Lau KF, Howlett DR et al (2002) Cyclin-dependent kinase-5/p35 phosphorylates Presenilin 1 to regulate carboxy-terminal fragment stability. Mol Cell Neurosci 20(1):13–20
57. Matrone C, Marolda R et al (2009) Tyrosine kinase nerve growth factor receptor switches from prosurvival to proapoptotic activity via Abeta-mediated phosphorylation. Proc Natl Acad Sci U S A 106(27):11358–11363
58. Cruz JC, Tsai LH (2004) Cdk5 deregulation in the pathogenesis of Alzheimer’s disease. Trends Mol Med 10(9):452–458
59. Holsinger RM, McLean CA et al (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer’s disease. Ann Neurol 51(6):783–786
60. Shukla V, Skuntz S et al (2012) Deregulated Cdk5 activity is involved in inducing Alzheimer’s disease. Arch Med Res 43(8):655–662
61. Mandelkow EM, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2(7):a006247
62. Castro-Alvarez JF, Uribe-Arias SA et al (2014) Long- and short-term CDK5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic Alzheimer’s mice. Front Aging Neurosci 6:243
63. Kimura T, Tsutsumi K et al (2013) Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites. J Biol Chem 288(11):7968–7977
64. Piedrahita D, Hernandez I et al (2010) Silencing of CDK5 reduces neurofibrillary tangles in transgenic Alzheimer’s mice. J Neurosci 30(42):13966–13976
65. Castro-Alvarez JF, Uribe-Arias SA et al (2014) Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach. Front Aging Neurosci 6:232
66. Lopes JP, Oliveira CR et al (2010) Neurodegeneration in an Abeta-induced model of Alzheimer’s disease: the role of Cdk5. Aging Cell 9(1):64–77
67. Kimura T, Ishiguro K et al (2014) Physiological and pathological phosphorylation of tau by Cdk5. Front Mol Neurosci 7:65
68. Takashima A, Murayama M et al (2001) Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain. Neurosci Lett 306(1-2):37–40
69. Lee S, Hall GF et al (2011) Potentiation of tau aggregation by cdk5 and GSK3beta. J Alzheimers Dis 26(2):355–364
70. Li X, Wang X et al (2014) Structural basis of valmerins as dual inhibitors of GSK3beta/CDK5. J Mol Model 20(9):2407
71. Jayapalan S, Natarajan J (2013) The role of CDK5 and GSK3B kinases in hyperphosphorylation of microtubule associated protein tau (MAPT) in Alzheimer’s disease. Bioinformation 9(20):1023–1030
72. Cuadrado-Tejedor M, Ricobaraza A et al (2011) Chronic mild stress in mice promotes cognitive impairment and CDK5-dependent tau hyperphosphorylation. Behav Brain Res 220(2):338–343
73. Cancino GI, Perez de Arce K et al (2011) c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice. Neurobiol Aging 32(7):1249–1261
74. Lee MS, Tsai LH (2003) Cdk5: one of the links between senile plaques and neurofibrillary tangles? J Alzheimers Dis 5(2):127–137
75. Chu J, Pratico D (2013) 5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5. Neurobiol Aging 34(6):1549–1554
76. Li L, Zhang C et al (2015) Epigenetic modulation of Cdk5 contributes to memory deficiency induced by amyloid fibrils. Exp Brain Res 233(1):165–173
77. Mota SI, Ferreira IL et al (2014) Dysfunctional synapse in Alzheimer’s disease—a focus on NMDA receptors. Neuropharmacology 76 Pt A:16–26
78. Price KA, Varghese M et al (2014) Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-beta oligomers and no plaque pathology. Mol Neurodegener 9:41
79. Su SC, Seo J et al (2012) Regulation of N-type voltage-gated calcium channels and presynaptic function by cyclin-dependent kinase 5. Neuron 75(4):675–687
80. Mishiba T, Tanaka M et al (2014) Cdk5/p35 functions as a crucial regulator of spatial learning and memory. Mol Brain 7(1):82
81. Maeder CI, Shen K et al (2014) Axon and dendritic trafficking. Curr Opin Neurobiol 27:165–170
82. Kim SH, Ryan TA (2010) CDK5 serves as a major control point in neurotransmitter release. Neuron 67(5):797–809
83. Marra V, Burden JJ et al (2012) A preferentially segregated recycling vesicle pool of limited size supports neurotransmission in native central synapses. Neuron 76(3):579–589
84. Xin X, Ferraro F et al (2004) Cdk5 and Trio modulate endocrine cell exocytosis. J Cell Sci 117(Pt 20):4739–4748
85. Peng YR, Hou ZH et al (2013) The kinase activity of EphA4 mediates homeostatic scaling-down of synaptic strength via activation of Cdk5. Neuropharmacology 65:232–243
86. Tan TC, Valova VA et al (2003) Cdk5 is essential for synaptic vesicle endocytosis. Nat Cell Biol 5(8):701–710
87. Goodwin PR, Sasaki JM et al (2012) Cyclin-dependent kinase 5 regulates the polarized trafficking of neuropeptide-containing dense-core vesicles in Caenorhabditis elegans motor neurons. J Neurosci 32(24):8158–8172
88. Ou CY, Poon VY et al (2010) Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components. Cell 141(5):846–858
89. Easley-Neal C, Fierro J Jr et al (2013) Late recruitment of synapsin to nascent synapses is regulated by Cdk5. Cell Rep 3(4):1199–1212
90. Plattner F, Hernandez A et al (2014) Memory enhancement by targeting Cdk5 regulation of NR2B. Neuron 81(5):1070–1083
91. Bianchetta MJ, Lam TT et al (2011) Cyclin-dependent kinase 5 regulates PSD-95 ubiquitination in neurons. J Neurosci 31(33):12029–12035
92. Yang L, Gu X et al (2014) Cdk5 inhibitor roscovitine alleviates neuropathic pain in the dorsal root ganglia by downregulating N-methyl-D-aspartate receptor subunit 2A. Neurol Sci 35(9):1365–1371
93. Brittain JM, Wang Y et al (2012) Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2. FEBS Lett 586(21):3813–3818
94. Fu AK, Fu WY et al (2001) Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat Neurosci 4(4):374–381
95. Higuchi O, Yamanashi Y (2011) Molecular mechanisms underlying the formation of neuromuscular junction. Brain Nerve 63(7):649–655
96. Fu AK, Fu WY et al (2004) Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity. Proc Natl Acad Sci U S A 101(17):6728–6733
97. Hou H, Sun L et al (2013) Synaptic NMDA receptor stimulation activates PP1 by inhibiting its phosphorylation by Cdk5. J Cell Biol 203(3):521–535
98. Lai KO, Wong AS et al (2012) TrkB phosphorylation by Cdk5 is required for activity-dependent structural plasticity and spatial memory. Nat Neurosci 15(11):1506–1515
99. Kim Y, Sung JY et al (2006) Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology. Nature 442(7104):814–817
100. Barros-Minones L, Martin-de-Saavedra D et al (2013) Inhibition of calpain-regulated p35/cdk5 plays a central role in sildenafil-induced protection against chemical hypoxia produced by malonate. Biochim Biophys Acta 1832(6):705–717
101. Gong X, Tang X et al (2003) Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38(1):33–46
102. Fang WQ, Ip JP et al (2011) Cdk5-mediated phosphorylation of Axin directs axon formation during cerebral cortex development. J Neurosci 31(38):13613–13624
103. Takano T, Tomomura M et al (2012) LMTK1/AATYK1 is a novel regulator of axonal outgrowth that acts via Rab11 in a Cdk5-dependent manner. J Neurosci 32(19):6587–6599
104. Qu J, Nakamura T et al (2011) S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide. Proc Natl Acad Sci U S A 108(34):14330–14335
105. Zhang P, Yu PC et al (2010) S-nitrosylation of cyclin-dependent kinase 5 (cdk5) regulates its kinase activity and dendrite growth during neuronal development. J Neurosci 30(43):14366–14370
106. van der Zee EA (2015) Synapses, spines and kinases in mammalian learning and memory, and the impact of aging. Neurosci Biobehav Rev 50:77–85
107. Yuzaki M (2011) Cbln1 and its family proteins in synapse formation and maintenance. Curr Opin Neurobiol 21(2):215–220
108. Samuels BA, Hsueh YP et al (2007) Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK. Neuron 56(5):823–837
109. Liu W, Zhang Y et al (2012) Nestin protects mouse podocytes against high glucose-induced apoptosis by a Cdk5-dependent mechanism. J Cell Biochem 113(10):3186–3196
110. Chang KH, de Pablo Y et al (2010) Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer’s disease. J Neurochem 113(5):1221–1229
111. Li X, Zhang HM et al (2012) Changes of cdk5, p35 and p53 gene expression levels in arsenic-induced neural cell apoptosis. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 30(2):85–88
112. Tian B, Yang Q et al (2009) Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat Cell Biol 11(2):211–218
113. Li BS, Zhang L et al (2002) Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J 21(3):324–333
114. Kim D, Frank CL et al (2008) Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 60(5):803–817
115. Brambrink AM, Evers AS et al (2010) Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology 112(4):834–841
116. Jiang H, Huang Y et al (2012) Hypoxia inducible factor-1alpha is involved in the neurodegeneration induced by isoflurane in the brain of neonatal rats. J Neurochem 120(3):453–460
117. Wang WY, Luo Y et al (2014) Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain. Neuropharmacology 77:90–99
118. Ke K, Shen J et al (2015) CDK5 contributes to neuronal apoptosis via promoting MEF2D phosphorylation in rat model of intracerebral hemorrhage. J Mol Neurosci 56(1):48–59
119. Kawauchi T, Shikanai M et al (2013) Extra-cell cycle regulatory functions of cyclin-dependent kinases (CDK) and CDK inhibitor proteins contribute to brain development and neurological disorders. Genes Cells 18(3):176–194
120. Lopes JP, Blurton-Jones M et al (2009) Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology. J Alzheimers Dis 16(3):541–549
121. Lopes JP, Oliveira CR et al (2009) Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides. Cell Cycle 8(1):97–104
122. Zhang J, Li H et al (2010) Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. J Neurosci 30(15):5219–5228
123. Minegishi S, Asada A et al (2010) Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39. Biochemistry 49(26):5482–5493
124. Chang KH, Vincent F et al (2012) Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death. J Cell Sci 125(Pt 21):5124–5137
125. Park J, Choi H et al (2015) Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells. J Neurochem 132(6):687–702
126. Cho B, Cho HM et al (2014) CDK5-dependent inhibitory phosphorylation of Drp1 during neuronal maturation. Exp Mol Med 46:e105
127. Fitzgerald JC, Camprubi MD et al (2012) Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function. Cell Death Differ 19(2):257–266
128. Weishaupt JH, Kussmaul L et al (2003) Inhibition of CDK5 is protective in necrotic and apoptotic paradigms of neuronal cell death and prevents mitochondrial dysfunction. Mol Cell Neurosci 24(2):489–502
129. Wu S, Zhou F et al (2011) Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins. FEBS J 278(6):941–954
130. Quintanilla RA, von Bernhardi R et al (2014) Phosphorylated tau potentiates Abeta-induced mitochondrial damage in mature neurons. Neurobiol Dis 71:260–269
131. Yoshida H, Kong YY et al (1998) Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94(6):739–750
132. Shi LL, Yang WN et al (2012) The protective effects of tanshinone IIA on neurotoxicity induced by beta-amyloid protein through calpain and the p35/Cdk5 pathway in primary cortical neurons. Neurochem Int 61(2):227–235
133. Zhang Z, Zhao R, Tang Y, Wen S, Wang D, Qi J (2012) Retraction note to: Fuzhisan, a Chinese herbal medicine, inhibits beta-amyloid-induced neurotoxicity and tau phosphorylation through calpain/Cdk5 pathway in cultured cortical neurons. Neurochem Res 37(4):902
134. Tian F, Xu LH et al (2014) The neuroprotective mechanism of puerarin in the treatment of acute spinal ischemia-reperfusion injury is linked to cyclin-dependent kinase 5. Neurosci Lett 584C:50–55
135. Zheng YL, Amin ND et al (2010) A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation. J Biol Chem 285(44):34202–34212